Literature DB >> 24191044

Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin.

Dagmara I Kisiela1, Victoria B Rodriguez, Veronika Tchesnokova, Hovhannes Avagyan, Pavel Aprikian, Yan Liu, Xue-Ru Wu, Wendy E Thomas, Evgeni V Sokurenko.   

Abstract

Inhibiting antibodies targeting receptor-binding pockets in proteins is a major focus in the development of vaccines and in antibody-based therapeutic strategies. Here, by using a common mannose-specific fimbrial adhesin of Escherichia coli, FimH, we demonstrate that locking the adhesin in a low-binding conformation induces the production of binding pocket-specific, adhesion-inhibiting antibodies. A di-sulfide bridge was introduced into the conformationally dynamic FimH lectin domain, away from the mannose-binding pocket but rendering it defective with regard to mannose binding. Unlike the native, functionally active lectin domain, the functionally defective domain was potent in inducing inhibitory monoclonal antibodies that blocked FimH-mediated bacterial adhesion to epithelial cells and urinary bladder infection in mice. Inhibition of adhesion involved direct competition between the antibodies and mannose for the binding pocket. Binding pocket-specific inhibitory antibodies also were abundant in polyclonal immune serum raised against the functionally defective lectin domain. The monoclonal antibodies elicited against the binding-defective protein bound to the high-affinity conformation of the adhesin more avidly than to the low-affinity form. However, both soluble mannose and blood plasma more strongly inhibited antibody recognition of the high-affinity FimH conformation than the low-affinity form. We propose that in the functionally active conformation the binding-pocket epitopes are shielded from targeted antibody development by ligand masking and that strong immunogenicity of the binding pocket is unblocked when the adhesive domain is in the nonbinding conformation.

Entities:  

Keywords:  FimH adhesin; antiadhesive antibodies

Mesh:

Substances:

Year:  2013        PMID: 24191044      PMCID: PMC3839742          DOI: 10.1073/pnas.1314395110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Synthetic peptide immunogens elicit polyclonal and monoclonal antibodies specific for linear epitopes in the D motifs of Staphylococcus aureus fibronectin-binding protein, which are composed of amino acids that are essential for fibronectin binding.

Authors:  M Huesca; Q Sun; R Peralta; G M Shivji; D N Sauder; M J McGavin
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Structural basis for mechanical force regulation of the adhesin FimH via finger trap-like beta sheet twisting.

Authors:  Isolde Le Trong; Pavel Aprikian; Brian A Kidd; Manu Forero-Shelton; Veronika Tchesnokova; Ponni Rajagopal; Victoria Rodriguez; Gianluca Interlandi; Rachel Klevit; Viola Vogel; Ronald E Stenkamp; Evgeni V Sokurenko; Wendy E Thomas
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

3.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli.

Authors:  Veronika Tchesnokova; Pavel Aprikian; Dagmara Kisiela; Sarah Gowey; Natalia Korotkova; Wendy Thomas; Evgeni Sokurenko
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

Review 5.  Cellular and molecular mechanisms of autoimmune disease.

Authors:  Brad Bolon
Journal:  Toxicol Pathol       Date:  2011-11-21       Impact factor: 1.902

6.  Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin.

Authors:  James R R Whittle; Ruijun Zhang; Surender Khurana; Lisa R King; Jody Manischewitz; Hana Golding; Philip R Dormitzer; Barton F Haynes; Emmanuel B Walter; M Anthony Moody; Thomas B Kepler; Hua-Xin Liao; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

7.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Authors:  S Langermann; R Möllby; J E Burlein; S R Palaszynski; C G Auguste; A DeFusco; R Strouse; M A Schenerman; S J Hultgren; J S Pinkner; J Winberg; L Guldevall; M Söderhäll; K Ishikawa; S Normark; S Koenig
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

8.  Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection.

Authors:  Chia-Suei Hung; Julie Bouckaert; Danielle Hung; Jerome Pinkner; Charlotte Widberg; Anthony DeFusco; C Gale Auguste; Robert Strouse; Solomon Langermann; Gabriel Waksman; Scott J Hultgren
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

9.  Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates.

Authors:  Iyadh Douagi; Mattias N E Forsell; Christopher Sundling; Sijy O'Dell; Yu Feng; Pia Dosenovic; Yuxing Li; Robert Seder; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

10.  A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity.

Authors:  Y Li; J Kim; T Diana; R Klasen; P D Olivo; G J Kahaly
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

View more
  6 in total

1.  Conformational switch of the bacterial adhesin FimH in the absence of the regulatory domain: Engineering a minimalistic allosteric system.

Authors:  Said Rabbani; Brigitte Fiege; Deniz Eris; Marleen Silbermann; Roman Peter Jakob; Giulio Navarra; Timm Maier; Beat Ernst
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

Review 2.  Neutralizing Antibodies Against Allosteric Proteins: Insights From a Bacterial Adhesin.

Authors:  Evgeni V Sokurenko; Veronika Tchesnokova; Gianluca Interlandi; Rachel Klevit; Wendy E Thomas
Journal:  J Mol Biol       Date:  2022-07-04       Impact factor: 6.151

3.  Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli.

Authors:  Dagmara I Kisiela; Hovhannes Avagyan; Della Friend; Aachal Jalan; Shivani Gupta; Gianluca Interlandi; Yan Liu; Veronika Tchesnokova; Victoria B Rodriguez; John P Sumida; Roland K Strong; Xue-Ru Wu; Wendy E Thomas; Evgeni V Sokurenko
Journal:  PLoS Pathog       Date:  2015-05-14       Impact factor: 6.823

4.  Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations.

Authors:  T Feenstra; M S Thøgersen; E Wieser; A Peschel; M J Ball; R Brandes; S C Satchell; T Stockner; F M Aarestrup; A J Rees; R Kain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-05       Impact factor: 3.267

Review 5.  Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation-The Example of FimH.

Authors:  Eva-Maria Krammer; Jerome de Ruyck; Goedele Roos; Julie Bouckaert; Marc F Lensink
Journal:  Molecules       Date:  2018-07-05       Impact factor: 4.411

6.  In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli.

Authors:  Sara Hasanzadeh; Mehri Habibi; Mohammad Ali Shokrgozar; Reza Ahangari Cohan; Khadijeh Ahmadi; Mohammad Reza Asadi Karam; Saeid Bouzari
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.